AI assistant
Sending…
CYTOKINETICS INC — Director's Dealing 2013
Sep 5, 2013
30870_dirs_2013-09-05_3d42aba6-1d24-473d-b9d8-5a8cba1267dc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2013-09-03
Reporting Person: Malik Fady Ibraham (SVP Research & Early Dev)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-09-03 | Common Stock | M | 14583 | — | Acquired | 29846 | Direct |
| 2013-09-03 | Common Stock | F | 5479 | $7.65 | Disposed | 24367 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-09-03 | Restricted Stock Units | $ | M | 14583 | Disposed | Common Stock (14583) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of CYTK common stock at a purchase price of $0.001 per share which is the current par value of the common stock.
F2: Shares withheld by Issuer to cover taxes associated with settlement of Restricted Stock Units
F3: The restricted stock units vest in two equal annual installments. Vested shares will be delivered to the reporting person on 9/4/2012 and 9/3/2013.
More from CYTOKINETICS INC
Share Issue/Capital Change
2026
May 27
Declaration of Voting Results & Voting Rights Announcements
2026
May 27
Share Issue/Capital Change
2026
May 7
Report Publication Announcement
2026
May 5
Annual Report
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18